S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q2 2021

BVF Partners

Periodo: Q2 2021 Β· Depositato: 2021-08-16
Vedi su SEC EDGAR β†—
AUM
$2.67B
Valore totale del portafoglio
Posizioni
70
Titoli dichiarati
Prima Posizione
GHRS
7.5% $201.6M
Var. Trimestrali
+8 / -6
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-08-16) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
GHRSGH RESEARCH PLC$201.6M7.55%$21.73$27.01+24.3%
7.5%
ARGXARGENX SE$196.1M7.35%$301.07$939.68+212.1%
7.3%
OLMAOLEMA PHARMACEUTICALS INC$186.4M6.99%$27.98$12.64-54.8%
7.0%
PTGXPROTAGONIST THERAPEUTICS INC$168.5M6.31%$44.88$131.62+193.3%
6.3%
MRUSMERUS N V$153.5M5.75%β€”β€”
5.8%
KYMRKYMERA THERAPEUTICS INC$127.6M4.78%$48.50$113.51+134.0%
4.8%
XOMAXOMA CORP DEL$120.0M4.50%$34.00$43.00+26.5%
4.5%
RPTXREPARE THERAPEUTICS INC$116.1M4.35%β€”β€”
4.3%
RLAYRELAY THERAPEUTICS INC$107.5M4.03%$36.59$18.65-49.0%
4.0%
RVMDREVOLUTION MEDICINES INC$78.9M2.96%$31.74$189.24+496.2%
3.0%
RCUSARCUS BIOSCIENCES INC$76.8M2.88%$27.46$30.33+10.4%
2.9%
EPIXESSA PHARMA INC$70.0M2.63%β€”β€”
2.6%
ACIUAC IMMUNE SA$67.8M2.54%$7.93$2.51-68.3%
2.5%
FDMT4D MOLECULAR THERAPEUTICS IN$48.3M1.81%$24.08$13.00-46.0%
1.8%
VSTMXXXXVERASTEM INC$45.9M1.72%β€”β€”
1.7%
SNDXSYNDAX PHARMACEUTICALS INC$42.7M1.60%$17.17$21.82+27.1%
1.6%
LXRXLEXICON PHARMACEUTICALS INC$38.5M1.44%$4.59$2.32-49.5%
1.4%
REPLREPLIMUNE GROUP INC$35.3M1.32%$38.42$11.58-69.9%
1.3%
VIRXVIRACTA THERAPEUTICS INC$35.1M1.32%β€”β€”
1.3%
KURAKURA ONCOLOGY INC$34.1M1.28%$20.85$11.10-46.8%
1.3%
RAINRAIN THERAPEUTICS INC$30.2M1.13%β€”$1.97
1.1%
SPROSPERO THERAPEUTICS INC$29.9M1.12%$13.96$2.20-84.2%
1.1%
JANXJANUX THERAPEUTICS INC$29.4M1.10%$24.95$15.54-37.7%
1.1%
XENEXENON PHARMACEUTICALS INC$29.3M1.10%$18.62$60.96+227.4%
1.1%
RACATHERAPEUTICS ACQUISITION COR$28.5M1.07%β€”β€”
1.1%
OVIDOVID THERAPEUTICS INC$25.9M0.97%$3.91$2.69-31.2%
1.0%
INFIQINFINITY PHARMACEUTICALS INC$25.1M0.94%$2.99$0.00
0.9%
IKNAIKENA ONCOLOGY INC$24.8M0.93%β€”β€”
0.9%
MTEMXXXXMOLECULAR TEMPLATES INC$22.3M0.84%β€”β€”
0.8%
CTICCTI BIOPHARMA CORP$22.3M0.84%β€”β€”
0.8%

AttivitΓ  Trimestre su Trimestre

Q2 2021 vs. Q1 2021

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
GHRSGH RESEARCH PLC$201.6M+24.3%
RAINRAIN THERAPEUTICS INC$30.2M
JANXJANUX THERAPEUTICS INC$29.4M-37.7%
ELEVELEVATION ONCOLOGY INC$21.6M
DAWNDAY ONE BIOPHARMACEUTICALS I$20.9M
NGMNGM BIOPHARMACEUTICALS INC$18.8M
ACRSACLARIS THERAPEUTICS INC$17.6M
CNTACENTESSA PHARMACEUTICALS PLC$1.3M

Posizioni Chiuse (6)

TickerEmittenteNozionale
FPRXFIVE PRIME THERAPEUTICS INC$238.8M
IONSIONIS PHARMACEUTICALS INC$61.4M
IDYAIDEAYA BIOSCIENCES INC$61.3M
CTMXCYTOMX THERAPEUTICS INC$43.1M
BCTGBCTG ACQUISITION CORP$8.9M
LSAQLIFESCI ACQUISITION II CORP$1.0M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SNDXSYNDAX PHARMACEUTICALS INC$39.0M+1420.5%+27.1%
RACATHERAPEUTICS ACQUISITION COR$20.4M+259.0%
ARGXARGENX SE$110.8M+110.3%+212.1%
PHXMERYTECH PHARMA$1.9M+110.3%
REPLREPLIMUNE GROUP INC$21.2M+99.1%-69.9%
FDMT4D MOLECULAR THERAPEUTICS IN$3.6M+94.5%-46.0%
RCUSARCUS BIOSCIENCES INC$24.1M+49.1%+10.4%
CALACALITHERA BIOSCIENCES INC$1.8M+31.1%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
XENEXENON PHARMACEUTICALS INC$-33.1M-54.9%+227.4%
ANABANAPTYSBIO INC$-4.7M-32.0%
CGEMCULLINAN ONCOLOGY INC$-24.8M-29.9%
RNACSELECTA BIOSCIENCES INC$-3.7M-28.8%
VRDNVIRIDIAN THERAPEUTICS INC$-1.3M-24.5%
XFORXXXXX4 PHARMACEUTICALS INC$-3.9M-22.3%
FWPAYFORWARD PHARMA A/S$0.1M-18.4%
FBRXFORTE BIOSCIENCES INC$-4.7M-17.7%
← Torna agli Hedge Fund